Treatment of Iron Deficiency Anemia in Patients with Tuberculosis
Intravenous iron should be considered as first-line treatment for iron deficiency anemia in patients with active tuberculosis, while oral iron supplementation is appropriate for those with mild anemia and inactive TB disease. 1, 2
Understanding Anemia in TB Patients
- Anemia is common in tuberculosis patients, with prevalence rates as high as 67% 2
- Two main types of anemia occur in TB patients:
- TB-associated anemia is primarily driven by inflammation-mediated mechanisms, including elevated hepcidin levels that block iron absorption 4
- During active TB infection, iron absorption is negligible (<1%) due to inflammatory processes 4
Diagnostic Approach
- Complete blood count, serum ferritin, and C-reactive protein should be used for laboratory screening 1
- In patients with active inflammation (elevated CRP), serum ferritin up to 100 μg/L may still be consistent with iron deficiency 1
- Consider measuring hepcidin levels if available - elevated levels (>20 ng/mL) predict poor response to oral iron 5, 4
- Monitor iron status every 3 months during TB treatment 1
Treatment Algorithm
For Active TB with Anemia:
First 2 months of TB treatment:
Dosing of IV iron:
After 2 months of TB treatment:
For Inactive TB or Post-Treatment with Anemia:
Oral iron supplementation:
Switch to IV iron if:
Monitoring and Follow-up
- Monitor hemoglobin response - expect increase of at least 2 g/dL within 4 weeks of treatment 1
- Goal of treatment: normalize hemoglobin levels and replenish iron stores 1
- After successful treatment, monitor for recurrent iron deficiency every 3 months for at least a year 1
Important Considerations
- Anemia of inflammation typically resolves with TB treatment alone, with significant improvement after 2 months 2, 4
- Iron supplementation during active TB inflammation may be ineffective due to poor absorption 4
- Iron is well absorbed only after TB treatment is completed; consider reserving supplementation for patients remaining anemic after treatment 4
- Recurrent anemia may indicate persistent disease activity even if other inflammatory parameters are normal 1
Pitfalls to Avoid
- Avoid oral iron during active inflammation as absorption is severely impaired 4
- Do not use intramuscular iron as it is painful, can damage tissues, and has unacceptable side effects 1
- Avoid iron overload by monitoring transferrin saturation (keep <50%) and serum ferritin (keep <800 μg/L) 1
- Do not delay TB treatment while addressing anemia, as treating the underlying TB is essential for resolving anemia of inflammation 2, 4